GDF3 AS BIOMARKER AND BIOTARGET IN POST-ISCHEMIC CARDIAC REMODELING Application WO-2022073915-A1 World Intellectual Property Organisation (WIPO) 14 Apr 2022
USE OF ALPHA-V-INTEGRIN (CD51) INHIBITORS FOR THE TREATMENT OF CARDIAC FIBROSIS Application WO-2020074937-A1 World Intellectual Property Organisation (WIPO) 16 Apr 2020
ALIGNMENT AND VARIANT SEQUENCING ANALYSIS PIPELINE Application EP-3274475-A4 European Patent Office 05 Dec 2018